Hangjun Zhan is Chief Scientific Officer of Kindred Biosciences, Inc.. Currently has a direct ownership of 0 shares of KIN, which is worth approximately $0. The most recent transaction as insider was on Aug 27, 2021, when has been sold 64,306 shares (Common Stock) at a price of $9.25 per share, resulting in proceeds of $594,830. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Hangjun Zhan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 27 2021
SELL
Sale (or disposition) back to the issuer
$594,830 $9.25 p/Share
64,306 Reduced 100.0%
0 Common Stock
Jan 23 2021
SELL
Payment of exercise price or tax liability
$16,688 $4.93 p/Share
3,385 Reduced 7.93%
39,306 Common Stock
Jan 22 2021
SELL
Payment of exercise price or tax liability
$16,688 $4.93 p/Share
3,385 Reduced 7.35%
42,691 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
-
6,250 Added 11.94%
46,076 Common Stock
Jan 17 2021
SELL
Payment of exercise price or tax liability
$16,756 $4.95 p/Share
3,385 Reduced 7.83%
39,826 Common Stock
Jan 17 2021
BUY
Exercise of conversion of derivative security
-
6,250 Added 12.64%
43,211 Common Stock
HZ

Hangjun Zhan

Chief Scientific Officer
Burlingame, CA

Track Institutional and Insider Activities on KIN

Follow Kindred Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KIN shares.

Notify only if

Insider Trading

Get notified when an Kindred Biosciences, Inc. insider buys or sells KIN shares.

Notify only if

News

Receive news related to Kindred Biosciences, Inc.

Track Activities on KIN